VISION
To systematically implement and apply model-based comparative medicine quantitative analyses for risk mitigation and support asset, investment and/or pipeline decision-making.
To stimulate learning and knowledge-generation from integrated comparative-medicine analyses of chronic diseases.
|
Challenges facing the
drug-development industry:
Pipeline pressures on the back
of patent expirations
Profitability in the face of declining
research & development budgets
An ageing patient population becoming
increasingly reliant on chronic medicines
Global epidemic threats
Fewer new targets, no more
low hanging fruit
Limited use of internal and
external historical data
SOLUTION
Leverage learning and historical knowledge integration by managing and analyzing available data efficiently to generate knowledge and novel insight and support decision-making
|
